Cross Country Healthcare, Inc. (CCRN)
NASDAQ: CCRN · Real-Time Price · USD
14.87
-0.02 (-0.13%)
At close: Apr 1, 2025, 4:00 PM
14.39
-0.48 (-3.20%)
After-hours: Apr 1, 2025, 4:30 PM EDT
Cross Country Healthcare Revenue
In the year 2024, Cross Country Healthcare had annual revenue of $1.34B, down -33.46%. Cross Country Healthcare had revenue of $309.94M in the quarter ending December 31, 2024, a decrease of -25.14%.
Revenue (ttm)
$1.34B
Revenue Growth
-33.46%
P/S Ratio
0.37
Revenue / Employee
$139,928
Employees
9,605
Market Cap
487.92M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.34B | -675.72M | -33.46% |
| Dec 31, 2023 | 2.02B | -783.65M | -27.95% |
| Dec 31, 2022 | 2.80B | 1.13B | 67.20% |
| Dec 31, 2021 | 1.68B | 840.24M | 100.46% |
| Dec 31, 2020 | 836.42M | 14.19M | 1.73% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 400.28B |
| Johnson & Johnson | 88.82B |
| Merck & Co. | 64.17B |
| AbbVie | 56.33B |
| AstraZeneca | 54.07B |
| Novartis AG | 51.72B |
| Eli Lilly and Company | 45.04B |
| Thermo Fisher Scientific | 42.88B |
CCRN News
- 27 days ago - Cross Country Healthcare Announces Fourth Quarter and Full Year 2024 Financial Results - Business Wire
- 4 weeks ago - Cross Country Healthcare Stockholders Approve Aya Healthcare Transaction - Business Wire
- 2 months ago - CROSS COUNTRY HEALTHCARE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Cross Country Healthcare, Inc. - CCRN - Business Wire
- 4 months ago - Cross Country's Susan E. Ball Recognized on SIA's Global Power 150 Women in Staffing - Business Wire
- 5 months ago - Cross Country Healthcare, Inc. (CCRN) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 5 months ago - Cross Country Healthcare Announces Third Quarter 2024 Financial Results - Business Wire
- 5 months ago - Cross Country Healthcare to Attend UBS Global Healthcare Conference - Business Wire
- 5 months ago - Cross Country Healthcare to Hold Third Quarter 2024 Earnings Conference Call on Wednesday, November 6, 2024 - Business Wire